The CSP team has more than 150 years of experience on Wall Street...
Cannabis Stock Picks will FOCUS on the key investments at the three levels...
We will cover the People, Places and Products the law allows and keep you posted...
- Q&A with CEO of CannaRoyalty (CNNRF), (CSE:CRZ), Marc Lustig
21 Jun 2017
CannaRoyalty is a fully integrated, active investor and operator in the legal cannabis sector. Our focus is building and supporting a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including research, consumer brands, devices and intellectual property. Our management team combines a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a platform of holdings via royalty agreements, equity interests, secured convertible debt, licensing agreements and its own branded portfolio. Mr. Lustig holds MSc and MBA degrees from McGill University. He began his professional career in the pharmaceutical industry at Merck & Co. In Click here to Read More
- CannaRoyalty Corp. (OTC: CNNRF)
17 Apr 2017
By Gary Anderson – CannaRoyalty Corp. (CNNRF): Unique Business Model a Big Winner in Cannabis Space CannaRoyalty Corp. (CNNRF) and (CSE:CRZ), has a unique business model in the cannabis space that minimizes risk and maximizes reward CannaRoyalty holds 22 strategic, diverse cannabis assets throughout North America Just one $850,000 investment in one cannabis asset now valued at $7.1M Exceptionally strong management team and board of directors positioning company to capitalize on high-growth cannabis market This article will provide an overview of CannaRoyalty’s intriguing business model and distinguished management team, and identify the company’s diversified cannabis assets. A future article will take Click here to Read More
- 22ND CENTURY GROUP, INC. (NYSEMKT: XXII)
30 Mar 2017
Company Overview: 22nd Century is a plant biotechnology company focused on technology, which allows the company to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company’s primary mission in tobacco is to reduce the harm caused by smoking. The company’s primary mission in cannabis is to develop proprietary cannabis strains for important new medicines and agricultural crops. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. Investment Thesis: The key Click here to Read More
- MassRoots Inc. (MSRT): Softened Stance from Attorney General Regarding Cannabis a Positive Driver
17 Mar 2017
MSRT shares lost 30% in recent weeks due to uncertainty in how the new administration in Washington will deal with the rapidly growing legalized cannabis industry in the U.S. However, Attorney General Jeff Sessions took a much more pragmatic stance on the cannabis industry in the U.S. just yesterday Expect shares of MSRT to rally in the coming days/weeks on yesterday’s clarification that erases much of the uncertainty that the market hates MSRT shares are bouncing off the 200 day moving average of .78 and look prime for a breakout MSRT is experiencing high sales growth and expects to be cash-flow positive in near term Cole Memorandum Click here to Read More
- CELEBRITY INVESTORS – WHOOPI GOLDBERG
21 Nov 2016
Cannabis Celebrity. This report published by cannabisstockpicks.com monitors celebrities that are involved in reaping profits from the cannabis industry. These people are profiting off of pot, under the radar or in the plain light of day, and sometimes to the surprise of many. They are business leaders, movie stars, and everything in between. This edition highlights Whoopi Goldberg. The View. We all knew Whoopi as a movie star. One of her most famous works being Sister Act. However, Whoopi transformed into a leading female voice on all sorts of issues through her time on The View, where she sat Click here to Read More